SCHEMBL5380662

SCHEMBL5380662

N#CCc1c(-c2ccccc2)cccc1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
DPP4 P27487 1/20 0.40
PDCD1 Q15116 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
ALDH1A1 P00352 4/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 2/20 0.39
BCL2L1 Q07817 1/20 0.39
CYP2A6 P11509 1/20 0.39
MAPK1 P28482 1/20 0.39
MMP3 P08254 1/20 0.39
EGFR P00533 1/20 0.38
SRC P12931 1/20 0.38
FOLH1 Q04609 1/20 0.37
TNF P01375 1/20 0.37
PTGS2 P35354 1/20 0.36
KDM4E B2RXH2 2/20 0.36
GALR3 O60755 1/20 0.36
GAA P10253 1/20 0.36
BACE1 P56817 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29788177 0.94 LMNA (0.39) LMNADPP4PDCD1CD274ALDH1A1
SCHEMBL30462313 0.88 DPP4 (0.44) LMNADPP4PDCD1CD274ALDH1A1
SCHEMBL5391697 0.84 GSTP1 (0.44) ALDH1A1HSD17B10MMP3TNFPTGS2
SCHEMBL7743971 0.78 RXRA (0.48) LMNAALDH1A1MAPK1TDP1
SCHEMBL1343377 0.77 DPP4 (0.56) LMNADPP4PDCD1CD274ALDH1A1
SCHEMBL4193873 0.77 HPRT1 (0.49) LMNAALDH1A1HPGDMAPK1MMP3
SCHEMBL13385994 0.76 LMNA (0.44) LMNADPP4PDCD1CD274ALDH1A1
SCHEMBL22234041 0.75 DPP4 (0.44) LMNADPP4PDCD1CD274ALDH1A1
SCHEMBL16056461 0.74 FOLH1 (0.62) DPP4PDCD1CD274ALDH1A1HPGD
SCHEMBL9570522 0.74 CD274 (0.65) DPP4PDCD1CD274ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7285682-B2 Terphenyl guanidines as β-secretase inhibitors WYETH (US) 2007-10-23 US disclosed
WO-2006088705-A1 TERPHENYL GUANIDINES AS [BETA SYMBOL] -SECRETASE INHIBITORS WYETH (US) 2006-08-24 WO disclosed
US-20060183943-A1 Terphenyl guanidines as beta-secretase inhibitors WYETH (US) 2006-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060183943-A1 Terphenyl guanidines as beta-secretase inhibitors BACE1, BACE2, APP LMNA 1130/4885DPP4 122/4885PDCD1 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.